Core Insights - The final rule for the 2026 Physician Fee Schedule by CMS aligns with the proposed rule and shows minimal changes from 2025 rates [1][2][3] - Reimbursement for the CPT code 97610 related to UltraMIST products remains largely unchanged, with payment rates for various treatment settings staying within $2-4 of 2025 levels [2][3] Summary by Sections Reimbursement Rates - The reimbursement for the 97610 code for UltraMIST products is expected to remain materially unchanged for 2026, with rates for physician offices, home visits, long-term care, and hospitals staying within $2-4 of 2025 rates [2] - Changes for 2026 are anticipated to be less than 1%, with many providers likely to see a slight increase in reimbursement [3] Company Response - In response to inquiries regarding UltraMIST reimbursement rates, the company provided an update confirming that the final 2026 rates are consistent with prior expectations [3] - The company plans to discuss these developments further during its third quarter earnings call [3]